Santa Cruz Biotechnology offers a broad range of Helicobacter pylori OMP monoclonal antibodies for research focused on understanding this significant pathogen. Helicobacter pylori OMP Antibodies are optimized for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Helicobacter pylori is a gram-negative bacterium that colonizes the gastric epithelium and is a major contributor to gastric diseases, including peptic ulcers and gastric cancer. The outer membrane proteins (OMPs) of Helicobacter pylori play crucial roles in pathogenicity, immune evasion, and interaction with host cells. Understanding OMP function and regulation is essential for developing targeted therapies and vaccines against H. pylori infections. Research into Helicobacter pylori OMPs continues to reveal new insights about bacterial survival mechanisms and host-pathogen interactions. Investigating OMP expression patterns helps identify potential therapeutic targets and biomarkers for disease progression. Current studies focus on characterizing the molecular mechanisms of OMP-mediated adhesion and colonization. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Helicobacter pylori pathogenesis and developing new therapeutic strategies.